Knott David M Jr
13F Reported Value
ⓘ$189.2M
Holdings
84
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Knott David M Jr disclosed 84 positions worth $189.2M in its Form 13F-HR for Q2 2026, led by $GOOGL (Alphabet Inc.) at 17.1% of the equity portfolio, followed by $APO and $SNDX. During the quarter the fund opened 8 new positions and exited 10 — including a new stake in $CLST and a full exit from $CPRX. The portfolio is most concentrated in Healthcare (52.5% of disclosed assets). All figures are sourced directly from Knott David M Jr’s Form 13F-HR filing with the SEC under CIK 1892770.
AI Fund Analysis
Concentrating
$GOOG
$APO
$SNDX
$XERS
$TVTX
$HELP
$ALKS
$PTHS$SNDX
$BBIOSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
- 78.2#57
Quality
$32.3M91,420 sh - 52.1#1,482
Quality
$26.6M225,000 sh - 33.8#2,378
Quality
$9.6M437,245 sh - 56.5
Quality
$8.4M1,060,000 sh - 56.6
Quality
$8.4M147,282 sh - 59.4
Quality
$7.7M63,000 sh - 36.9
Quality
$6.9M92,850 sh - 36.8
Quality
$6.7M1,600,000 sh - —
Quality
$6.4M121,759 sh - 70.7
Quality
$5.9M18,098 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 Alphabet Inc.$GOOGL | 78.2#57 | $32.3M | 91,420 |
| Apollo Global Management, Inc.$APO | 52.1#1,482 | $26.6M | 225,000 |
| Syndax Pharmaceuticals Inc$SNDX | 33.8#2,378 | $9.6M | 437,245 |
| Xeris Biopharma Holdings, Inc.$XERS | 56.5 | $8.4M | 1,060,000 |
| Travere Therapeutics, Inc.$TVTX | 56.6 | $8.4M | 147,282 |
 Protagonist Therapeutics, Inc$PTGX | 59.4 | $7.7M | 63,000 |
| BridgeBio Pharma, Inc.$BBIO | 36.9 | $6.9M | 92,850 |
 IOVANCE BIOTHERAPEUTICS, INC.$IOVA | 36.8 | $6.7M | 1,600,000 |
| Alkermes plc.$ALKS | — | $6.4M | 121,759 |
 JPMORGAN CHASE & CO$JPM | 70.7 | $5.9M | 18,098 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Knott David M Jr's 84 positions.
Showing top 10 of 84 holdings.
Sector Allocation
Healthcare
$99.4M
Financials
$38.0M
Technology
$34.3M
Other
$14.2M
Industrials
$1.1M
Materials
$807,400
Energy
$690,647
Real Estate
$315,072
Full Holdings — Knott David M Jr (Q2 2026)
All 84 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $GOOGL | Alphabet Inc. | $32.3M | 17.1% | +0% | 78.2 |
| 2 | $APO | Apollo Global Management, Inc. | $26.6M | 14.1% | +0% | 52.1 |
| 3 | $SNDX | Syndax Pharmaceuticals Inc | $9.6M | 5.0% | +4% | 33.8 |
| 4 | $XERS | Xeris Biopharma Holdings, Inc. | $8.4M | 4.4% | +0% | 56.5 |
| 5 | $TVTX | Travere Therapeutics, Inc. | $8.4M | 4.4% | +5% | 56.6 |
| 6 | $PTGX | Protagonist Therapeutics, Inc | $7.7M | 4.1% | +0% | 59.4 |
| 7 | $BBIO | BridgeBio Pharma, Inc. | $6.9M | 3.7% | +3% | 36.9 |
| 8 | $IOVA | IOVANCE BIOTHERAPEUTICS, INC. | $6.7M | 3.5% | +0% | 36.8 |
| 9 | $ALKS | Alkermes plc. | $6.4M | 3.4% | +1% | — |
| 10 | $JPM | JPMORGAN CHASE & CO | $5.9M | 3.1% | -7% | 70.7 |
| 11 | — | Janus Henderson AAA CLO ETF - Common | $4.7M | 2.5% | +0% | — |
| 12 | — | LPL Financial Holdings Inc. - Common | $4.6M | 2.5% | +0% | — |
| 13 |  $COGT | Cogent Biosciences, Inc. | $4.3M | 2.3% | +7% | — |
| 14 |  $TGTX | TG THERAPEUTICS, INC. | $3.7M | 1.9% | -26% | 69.3 |
| 15 |  $CLST | Catalyst Bancorp, Inc. | $3.6M | 1.9% | NEW | 55 |
| 16 |  $AGIO | AGIOS PHARMACEUTICALS, INC. | $3.5M | 1.9% | +2% | 26.9 |
| 17 |  $VRDN | Viridian Therapeutics, Inc.\DE | $3.3M | 1.8% | +0% | 27.2 |
| 18 |  $RLMD | RELMADA THERAPEUTICS, INC. | $3.1M | 1.6% | +3% | — |
| 19 |  $RCUS | Arcus Biosciences, Inc. | $2.5M | 1.3% | +0% | 8.5 |
| 20 | $HELP | CYBIN INC. | $2.4M | 1.3% | +6% | — |
| 21 | — | SPDR S&P Biotech ETF - Common | $2.4M | 1.3% | +0% | — |
| 22 |  $RZLT | Rezolute, Inc. | $1.9M | 1.0% | +0% | — |
| 23 |  $AB | ALLIANCEBERNSTEIN HOLDING L.P. | $1.7M | 0.9% | +0% | — |
| 24 |  $MDGL | MADRIGAL PHARMACEUTICALS, INC. | $1.6M | 0.8% | +50% | 40.7 |
| 25 |  $ATRC | AtriCure, Inc. | $1.4M | 0.8% | +0% | 59 |
| 26 |  $DCGO | DocGo Inc. | $1.4M | 0.7% | +0% | 15.2 |
| 27 |  $ARDX | ARDELYX, INC. | $1.3M | 0.7% | +27% | 41.9 |
| 28 |  $RARE | Ultragenyx Pharmaceutical Inc. | $1.3M | 0.7% | +15% | 34.2 |
| 29 | — | The Panagram BBB-B CLO ETF - Common | $1.3M | 0.7% | +0% | — |
| 30 |  $CGEM | Cullinan Therapeutics, Inc. | $1.3M | 0.7% | +186% | — |
| 31 |  $JNJ | JOHNSON & JOHNSON | $1.3M | 0.7% | +0% | 69 |
| 32 |  $VERA | Vera Therapeutics, Inc. | $1.1M | 0.6% | +0% | — |
| 33 |  $OBIO | Orchestra BioMed Holdings, Inc. | $1.1M | 0.6% | +0% | 32 |
| 34 |  $SPRB | SPRUCE BIOSCIENCES, INC. | $1.1M | 0.6% | NEW | — |
| 35 |  $CNTB | Connect Biopharma Holdings Ltd | $1.1M | 0.6% | +15% | — |
| 36 | — | iShares Biotechnology ETF - Common | $1.0M | 0.6% | +0% | — |
| 37 |  $BIIB | BIOGEN INC. | $864,240 | 0.5% | +0% | 64.7 |
| 38 |  $PFE | PFIZER INC | $778,675 | 0.4% | +0% | 62 |
| 39 |  $AAPL | Apple Inc. | $721,664 | 0.4% | +0% | 76.4 |
| 40 |  $CNQ | CANADIAN NATURAL RESOURCES Ltd | $663,600 | 0.3% | +0% | — |
| 41 | $PTHS | Pelthos Therapeutics Inc. | $623,783 | 0.3% | +5% | 17.5 |
| 42 |  $IBM | INTERNATIONAL BUSINESS MACHINES CORP | $602,352 | 0.3% | +0% | 70 |
| 43 |  $MSFT | MICROSOFT CORP | $596,832 | 0.3% | +0% | 79.8 |
| 44 |  $VSTM | Verastem, Inc. | $592,100 | 0.3% | +49% | 29.7 |
| 45 |  $KURA | Kura Oncology, Inc. | $578,854 | 0.3% | +0% | 27.6 |
| 46 |  $SLDB | Solid Biosciences Inc. | $561,518 | 0.3% | +19% | — |
| 47 |  $DD | DuPont de Nemours, Inc. | $510,956 | 0.3% | +0% | 47 |
| 48 |  $INSM | INSMED Inc | $453,455 | 0.2% | NEW | 39.4 |
| 49 |  $LBRX | LB PHARMACEUTICALS INC | $420,779 | 0.2% | NEW | — |
| 50 |  $CDNA | CareDx, Inc. | $388,455 | 0.2% | NEW | 67.5 |
| 51 |  $FIXX | Q32 Bio Inc. | $387,449 | 0.2% | NEW | 36.4 |
| 52 |  $ELVN | Enliven Therapeutics, Inc. | $313,787 | 0.2% | NEW | — |
| 53 |  $RHP | Ryman Hospitality Properties, Inc. | $308,520 | 0.2% | +0% | 65.1 |
| 54 |  $AVGO | Broadcom Inc. | $268,202 | 0.1% | +0% | 84.5 |
| 55 |  $KMB | KIMBERLY CLARK CORP | $263,448 | 0.1% | +0% | 58.7 |
| 56 |  $NVDA | NVIDIA CORP | $256,115 | 0.1% | +0% | 85.9 |
| 57 |  $BSX | BOSTON SCIENTIFIC CORP | $256,080 | 0.1% | NEW | 77.5 |
| 58 |  $WVE | Wave Life Sciences, Inc. | $232,400 | 0.1% | +0% | 7.5 |
| 59 |  $RAIN | Rain Enhancement Technologies Holdco, Inc. | $210,490 | 0.1% | +0% | — |
| 60 |  $MDLZ | Mondelez International, Inc. | $173,520 | 0.1% | +0% | 56.4 |
| 61 |  $PWR | QUANTA SERVICES, INC. | $126,727 | 0.1% | +0% | 72.1 |
| 62 |  $BMY | BRISTOL MYERS SQUIBB CO | $115,240 | 0.1% | -85% | 70.4 |
| 63 |  $EBC | Eastern Bankshares, Inc. | $111,200 | 0.1% | +0% | 69.5 |
| 64 | $GOOG | Alphabet Inc. | $107,211 | 0.1% | +0% | 78.2 |
| 65 |  $LEGH | Legacy Housing Corp | $105,080 | 0.1% | +0% | 50 |
| 66 |  $CTVA | Corteva, Inc. | $102,136 | 0.1% | +0% | 47.2 |
| 67 | — | iShares Russell Mid-Cap Growth - Common | $101,755 | 0.1% | +0% | — |
| 68 |  $URI | UNITED RENTALS, INC. | $88,365 | 0.1% | +0% | 63.9 |
| 69 |  $IVVD | Invivyd, Inc. | $87,240 | 0.1% | +0% | 29.7 |
| 70 |  $AMZN | AMAZON COM INC | $71,502 | 0.0% | +0% | 68.7 |
| 71 |  $DHR | DANAHER CORP /DE/ | $34,286 | 0.0% | +0% | 64.8 |
| 72 |  $DOW | DOW INC. | $32,996 | 0.0% | +0% | 40.2 |
| 73 |  $FSK | FS KKR Capital Corp | $30,187 | 0.0% | +0% | — |
| 74 |  $BRSL | Brightstar Lottery PLC | $26,800 | 0.0% | +0% | — |
| 75 |  $BX | Blackstone Inc. | $24,711 | 0.0% | +0% | 74.4 |
| 76 |  $UNH | UNITEDHEALTH GROUP INC | $23,691 | 0.0% | +0% | 62.7 |
| 77 |  $OXY | OCCIDENTAL PETROLEUM CORP /DE/ | $22,779 | 0.0% | -29% | 62.6 |
| 78 |  $TMO | THERMO FISHER SCIENTIFIC INC. | $22,561 | 0.0% | +0% | 65.1 |
| 79 |  $CRM | Salesforce, Inc. | $12,063 | 0.0% | +0% | 77 |
| 80 |  $STWD | STARWOOD PROPERTY TRUST, INC. | $6,552 | 0.0% | +0% | 68.4 |
| 81 |  $KD | Kyndryl Holdings, Inc. | $4,841 | 0.0% | +0% | 50.1 |
| 82 | $OXY | OCCIDENTAL PETROLEUM CORP /DE/ | $4,268 | 0.0% | NEW | 62.6 |
| 83 |  $GEHC | GE HealthCare Technologies Inc. | $3,200 | 0.0% | +0% | 55.7 |
| 84 |  $WAB | WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP | $1,618 | 0.0% | +0% | 66.3 |
New Positions (8)
Exited Positions (10)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Knott David M Jr including:
Track Knott David M Jr's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Knott David M Jr and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Knott David M Jr
13F Pro is an AI hedge fund tracker and stock research platform. For Knott David M Jr (SEC CIK: 1892770), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Knott David M Jr's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.